Tectonic Therapeutic Inc

NAS:TECX (USA)  
$ 30.97 -0.76 (-2.38%) 10:08 PM EST
At Loss
P/B:
2.76
Market Cap:
$ 456.33M
Enterprise V:
$ 289.23M
Volume:
54.22K
Avg Vol (2M):
96.21K
Trade In:
Volume:
54.22K
At Loss
Avg Vol (2M):
96.21K

Business Description

Tectonic Therapeutic Inc
NAICS : 541713 SIC : 2834
ISIN : US8789721086
Compare
Compare
Traded in other countries / regions
TECX.USA
IPO Date
2024-06-21
Description
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
Name Current Vs Industry Vs History
Cash-To-Debt 53.75
Equity-to-Asset 0.86
Debt-to-Equity 0.02
Debt-to-EBITDA -0.16
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y EPS without NRI Growth Rate -25.98

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 58.17
9-Day RSI 66.49
14-Day RSI 69.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.21
Quick Ratio 7.21
Cash Ratio 7.12

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 0.36
Name Current Vs Industry Vs History
ROE % -52.49
ROA % -21.67
ROIC % -171.35
ROC (Joel Greenblatt) % -329.14
ROCE % -26.39

Financials (Next Earnings Date:2024-11-29 Est.)

TECX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TECX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tectonic Therapeutic Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.542
Beta 0
Volatility % 0
14-Day RSI 69.23
14-Day ATR ($) 1.98887
20-Day SMA ($) 25.5775
12-1 Month Momentum % 0
52-Week Range ($) 15.0001 - 34.5
Shares Outstanding (Mil) 14.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tectonic Therapeutic Inc Filings

Filing Date Document Date Form
No Filing Data

Tectonic Therapeutic Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Tectonic Therapeutic Inc Frequently Asked Questions

What is Tectonic Therapeutic Inc(TECX)'s stock price today?
The current price of TECX is $30.97. The 52 week high of TECX is $34.50 and 52 week low is $15.00.
When is next earnings date of Tectonic Therapeutic Inc(TECX)?
The next earnings date of Tectonic Therapeutic Inc(TECX) is 2024-11-29 Est..
Does Tectonic Therapeutic Inc(TECX) pay dividends? If so, how much?
Tectonic Therapeutic Inc(TECX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1